Translational Development Acquisition Corp. Ordinary Shares (TDAC) — Working Capital to Net Assets Ratio
Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a Working Capital to Net Assets ratio of -0.2% as of September 2025. Working capital of $-342.26K (current assets of $80.58K minus current liabilities of $422.85K) is measured against net assets of $173.52 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Translational Development Acquisition Corp. Ordinary Shares Working Capital to Net Assets (2022–2024)
This chart shows how Translational Development Acquisition Corp. Ordinary Shares's Working Capital to Net Assets ratio has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the ratio stands at -0.2%, reflecting working capital of $-342.26K against net assets of $173.52 Million USD. For the complete balance sheet picture, see how large is Translational Development Acquisition Co's balance sheet.
Annual Working Capital to Net Assets for Translational Development Acquisition Corp. Ordinary Shares (2022–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Translational Development Acquisition Corp. Ordinary Shares from 2022 to 2024, covering 3 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read Translational Development Acquisition Co total liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.3% | $439.93K | $168.75 Million | $650.23K | $210.30K | ▼ -99.7 pp |
| 2023 | 100.0% | $-507.66K | $-507.66K | $2.02K | $509.68K | ▼ -1732.7 pp |
| 2022 | 1832.7% | $-405.17K | $-22.11K | $54.23K | $459.39K | — |